CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $44,199 | -34.9% | 75,722 | 0.0% | 0.01% | -42.9% |
| Q1 2024 | $67,945 | +18.6% | 75,722 | 0.0% | 0.01% | +7.7% |
| Q4 2023 | $57,284 | +10.5% | 75,722 | 0.0% | 0.01% | 0.0% |
| Q3 2023 | $51,824 | -43.1% | 75,722 | 0.0% | 0.01% | -40.9% |
| Q2 2023 | $91,000 | +2.2% | 75,722 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $89,000 | -3.3% | 75,722 | 0.0% | 0.02% | -15.4% |
| Q3 2022 | $92,000 | +31.4% | 75,722 | 0.0% | 0.03% | +36.8% |
| Q2 2022 | $70,000 | -48.5% | 75,722 | 0.0% | 0.02% | -42.4% |
| Q1 2022 | $136,000 | +16.2% | 75,722 | 0.0% | 0.03% | +13.8% |
| Q4 2021 | $117,000 | -24.0% | 75,722 | 0.0% | 0.03% | -31.0% |
| Q3 2021 | $154,000 | -41.7% | 75,722 | 0.0% | 0.04% | -43.2% |
| Q2 2021 | $264,000 | +200.0% | 75,722 | +52.7% | 0.07% | +164.3% |
| Q1 2021 | $88,000 | – | 49,590 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 198,632 | $232,399 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 452,561 | $529 | 0.05% |
| Wealth Advisory Solutions, LLC | 155,850 | $182,345 | 0.05% |
| CHELSEA COUNSEL CO | 81,300 | $95,121 | 0.05% |
| Horst & Graben Wealth Management LLC | 75,722 | $89,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $58,500 | 0.01% |
| Pasadena Private Wealth, LLC | 10,965 | $12,829 | 0.00% |
| Jump Financial, LLC | 66,143 | $77,387 | 0.00% |
| Lighthouse Investment Partners, LLC | 36,126 | $42,267 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 75,188 | $87,970 | 0.00% |